What's Happening?
Health Secretary Robert F. Kennedy, Jr. has appointed two new members to the CDC’s Advisory Committee on Immunization Practices (ACIP) ahead of a rescheduled meeting in March. The new appointees, Sean Downing and Angelina Farella, bring extensive experience
in internal medicine and pediatrics. This move is part of Kennedy's broader effort to overhaul the ACIP, which began in June 2025 when he dismissed all 17 previous members to restore public confidence in vaccine science. The ACIP advises the CDC on vaccine recommendations, although the CDC is not obligated to follow its advice. The upcoming meeting will address issues related to COVID-19 vaccine injuries and long COVID. The committee has recently recommended delaying hepatitis B vaccinations for certain infants and removed several vaccines from the children's schedule, decisions that have sparked controversy.
Why It's Important?
The changes to the ACIP and its recommendations have significant implications for public health policy and vaccine confidence in the U.S. The appointment of new members who share Kennedy's skepticism towards vaccines could influence the committee's future recommendations, potentially affecting vaccine uptake and public trust. The American Academy of Pediatrics has challenged these changes legally, arguing they undermine public confidence in vaccines. The outcome of this legal battle could set precedents for how health policy is shaped and contested in the U.S. The ongoing controversies and leadership changes at the CDC may also impact the agency's ability to effectively manage public health initiatives.
What's Next?
The rescheduled ACIP meeting on March 18-19 will be crucial in determining the future direction of U.S. vaccine policy. Discussions will focus on COVID-19 vaccine-related injuries and long COVID, which could lead to further changes in vaccine recommendations. The legal case brought by the American Academy of Pediatrics against the Department of Health and Human Services continues, with a federal judge recently delaying a decision to allow more time for government responses. The outcome of this case could influence future health policy decisions and the structure of advisory committees like the ACIP.
